A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target cellular receptors called GPCRs, potentially rendering these important drugs less effective.
Drugs that act on GPCRs, or G protein-coupled receptors, include more than 400 medications approved by the U.S. Food and Drug Administration (FDA) for treatment of many common conditions such as migraines, depression, type 2 diabetes,...
Can SMELL Really Detect SCHIZOPHRENIA Better Than Current Methods?
Anecdotal Evidence and Observations
Michelle Hammer, who has schizophrenia, initially dismissed the idea that people with...
Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers of the University of Barcelona have identified a...
Summary: People with schizophrenia experience impaired contrast perception, affecting their ability to differentiate light intensity and recognize shapes and textures. This deficit may...
